Better survival with lobectomy versus sublobar resection in patients with hypermetabolic c-stage IA lung cancer on positron emission tomography/computed tomography.

ABSTRACT:

Objectives

The clinical trial showed that sublobar resection was not inferior to lobectomy in terms of disease-free survival in patients with peripherally located non-small-cell lung cancer ≤2 cm. However, it is not clear whether sublobar resection is indicated for all types of c-stage IA lung cancer. The purpose of this study was to clarify whether sublobar resection is indicated for c-stage IA hypermetabolic lung cancer.

Methods

Patients with c-stage IA lung cancer who underwent F-18 fluorodeoxyglucose positron emission tomography/computed tomography and lobectomy or sublobar resection were assessed. Of these, patients who had a maximum standardized uptake value ≥3.0 on positron emission tomography/computed tomography were evaluated. We compared survival rates after lobect

SUBMITTER: Shiono S 

PROVIDER: S-EPMC11460284 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature